Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - methadone hydrochloride, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: glycerol; sodium benzoate; purified water; sorbitol solution (70 per cent) (non-crystallising); ethanol; sunset yellow fcf; flavour - methadone syrup is indicated for the treatment of dependence on opioid drugs.,methadone syrup is indicated for the management of severe pain where: (i) other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and (ii) the pain is opioid-responsive, and (iii) requires daily, continuous, long-term treatment.,methadone syrup is not indicated for use in chronic non-cancer pain other than in exceptional circumstances.,methadone syrup is not indicated as an as-needed (prn) analgesia.,methadone syrup is not recommended for use in ambulant patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ciprofloxacin -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fluconazole -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adenosine -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methadone hydrochloride, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; glycerol; maize starch; gelatin - aspen methadone tablets is indicated for the management of severe pain where: (i) other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and (ii) the pain is opioid-responsive, and (iii) requires daily, continuous, long-term treatment. ,aspen methadone tablets is not indicated for use in chronic non-cancer pain other than in exceptional circumstances.,aspen methadone tablets is not indicated as an as-needed (prn) analgesia.,aspen methadone tablets is not recommended for use in ambulant patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methadone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections - aspen methadone injection is indicated for the management of severe pain where: (i) other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and (ii) the pain is opioid-responsive, and (iii) requires daily, continuous, long-term treatment. ,aspen methadone injection is not indicated for use in chronic non-cancer pain other than in exceptional circumstances.,aspen methadone injection is not indicated as an as-needed (prn) analgesia.,aspen methadone injection is not recommended for use in ambulant patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: dextrin; magnesium stearate; lactose monohydrate; maize starch - aspen-levothyroxine is indicated for the management of demonstrated thyroid hormone deficiency.,aspen-levothyroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: dextrin; lactose monohydrate; maize starch; magnesium stearate - aspen-levothyroxine is indicated for the management of demonstrated thyroid hormone deficiency.,aspen-levothyroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; maize starch; lactose monohydrate - aspen-levothyroxine is indicated for the management of demonstrated thyroid hormone deficiency.,aspen-levothyroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.